Clarification2 Jun 2026, 02:23 pm
Gufic Biosciences Clarifies Share Subscription in Saraswat Bank
AI Summary
Gufic Biosciences has issued a corrigendum to clarify its subscription to shares of Saraswat Co-operative Bank Limited. The company stated that the subscription is a mandatory share-linkage requirement for its existing credit facilities of approximately ₹230 crore, as per RBI norms for borrower members. The company emphasized that this transaction does not constitute an acquisition, strategic investment, or change in control, as the bank operates under a 'one member, one vote' principle.
Key Highlights
- Subscription is a mandatory share-linkage requirement for existing credit facilities of ₹230 crore.
- The transaction is not an acquisition or strategic investment in Saraswat Bank.
- Subscription does not confer additional voting rights, management control, or ownership interest.
- The action is in line with RBI Master Circular on Prudential Norms for Co-operative Banks.
Price Impact
More from GUFICBIO